Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders (LPD) and EBV-Positive Non-Hodgkin Lymphomas (NHL)
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
EBV associated lymphoproliferative disorder, non-Hodgkin lymphoma, nivolumab, Phase 2 trial, immunotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要